Clinical insights, laboratory science, drug use trends, and company news from Optimus Labs.
Fentanyl-related overdose fatalities are showing a meaningful decline for the first time in years, according to the latest Optimus Labs Insight Report. However, our data scientists have identified a sharp and concerning rise in illicit stimulant use — particularly methamphetamine co-detected alongside other substances — that threatens to reshape the drug overdose landscape in the United States.
Read Full ReportA comprehensive analysis of UDT data reveals significant patterns in gabapentin use with and without prescriptions across substance use treatment settings nationwide.
Read MoreOur selection to the UHC Preferred Lab Network for the sixth consecutive year reflects our unwavering commitment to clinical quality and billing transparency.
Read MoreGet the Insight Report and clinical updates delivered to your inbox.